| Year |
Citation |
Score |
| 2022 |
Buonato JM, Edwards JP, Zaritskaya L, Witter AR, Gupta A, LaFleur DW, Tice DA, Richman LK, Hilbert DM. Preclinical Efficacy of BCMA-Directed CAR T Cells Incorporating a Novel D Domain Antigen Recognition Domain. Molecular Cancer Therapeutics. OF1-OF13. PMID 35737298 DOI: 10.1158/1535-7163.MCT-21-0552 |
0.324 |
|
| 2020 |
Mu J, Edwards J, Zaritskaya L, Swers J, Gupta A, LaFleur D, Hilbert D, Richman L. Selective targeting of HER2-overexpressing solid tumors with a next-generation CAR-T cell therapy. Journal of Clinical Oncology. 38: 3041-3041. DOI: 10.1200/Jco.2020.38.15_Suppl.3041 |
0.386 |
|
| 2019 |
Qin H, Edwards JP, Zaritskaya L, Gupta A, Mu CJ, Fry TJ, Hilbert DM, LaFleur DW. Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono- and Bi-specific Antitumor Activity of T Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31043341 DOI: 10.1016/J.Ymthe.2019.04.010 |
0.309 |
|
| 2012 |
Stohl W, Hilbert DM. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nature Biotechnology. 30: 69-77. PMID 22231104 DOI: 10.1038/Nbt.2076 |
0.363 |
|
| 2008 |
Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, Korsmeyer SJ, Hilbert DM, Thompson CB. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood. 111: 750-60. PMID 17942753 DOI: 10.1182/Blood-2007-03-077222 |
0.679 |
|
| 2006 |
Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis and Rheumatism. 54: 723-32. PMID 16508933 DOI: 10.1002/Art.21650 |
0.562 |
|
| 2004 |
Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Roschke V, Wu Y, Baker KP, Hilbert DM. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 63: 1096-103. PMID 15308519 DOI: 10.1136/Ard.2003.018663 |
0.335 |
|
| 2003 |
Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis and Rheumatism. 48: 3475-86. PMID 14673998 DOI: 10.1002/Art.11354 |
0.431 |
|
| 2003 |
Baker KP, Edwards BM, Main SH, Choi GH, Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L, Sturm B, Poortman C, Minter RR, Dobson CL, Williams E, ... ... Hilbert DM, et al. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis and Rheumatism. 48: 3253-65. PMID 14613291 DOI: 10.1002/Art.11299 |
0.568 |
|
| 2003 |
Stewart DM, McAvoy MJ, Hilbert DM, Nelson DL. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clinical Immunology (Orlando, Fla.). 109: 137-43. PMID 14597212 DOI: 10.1016/S1521-6616(03)00215-8 |
0.591 |
|
| 2003 |
Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis and Rheumatism. 48: 982-92. PMID 12687540 DOI: 10.1002/Art.10860 |
0.452 |
|
| 2002 |
Nardelli B, Moore PA, Li Y, Hilbert DM. B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases. Leukemia & Lymphoma. 43: 1367-73. PMID 12389615 DOI: 10.1080/10428190290033297 |
0.632 |
|
| 2002 |
Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V, Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. Journal of Immunology (Baltimore, Md. : 1950). 169: 4314-21. PMID 12370363 DOI: 10.4049/Jimmunol.169.8.4314 |
0.378 |
|
| 2002 |
Stohl W, Cheema GS, Briggs WS, Xu D, Sosnovtseva S, Roschke V, Ferrara DE, Labat K, Sattler FR, Pierangeli SS, Hilbert DM. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients. Clinical Immunology (Orlando, Fla.). 104: 115-22. PMID 12165272 DOI: 10.1006/Clim.2002.5238 |
0.38 |
|
| 2002 |
Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nature Immunology. 3: 822-9. PMID 12154359 DOI: 10.1038/Ni829 |
0.442 |
|
| 2002 |
Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. Journal of Immunology (Baltimore, Md. : 1950). 168: 5993-6. PMID 12055205 DOI: 10.4049/Jimmunol.168.12.5993 |
0.66 |
|
| 2002 |
Briones J, Timmerman JM, Hilbert DM, Levy R. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Experimental Hematology. 30: 135-41. PMID 11823048 DOI: 10.1016/S0301-472X(01)00774-3 |
0.503 |
|
| 2001 |
Harless SM, Lentz VM, Sah AP, Hsu BL, Clise-Dwyer K, Hilbert DM, Hayes CE, Cancro MP. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Current Biology : Cb. 11: 1986-9. PMID 11747827 DOI: 10.1016/S0960-9822(01)00598-X |
0.57 |
|
| 2001 |
Cheema GS, Roschke V, Hilbert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis and Rheumatism. 44: 1313-9. PMID 11407690 DOI: 10.1002/1529-0131(200106)44:6<1313::Aid-Art223>3.0.Co;2-S |
0.37 |
|
| 2001 |
Kanakaraj P, Migone TS, Nardelli B, Ullrich S, Li Y, Olsen HS, Salcedo TW, Kaufman T, Cochrane E, Gan Y, Hilbert DM, Giri J. BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1. Cytokine. 13: 25-31. PMID 11145839 DOI: 10.1006/Cyto.2000.0793 |
0.515 |
|
| 2001 |
Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood. 97: 198-204. PMID 11133761 DOI: 10.1182/Blood.V97.1.198 |
0.556 |
|
| 2000 |
Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. The Journal of Experimental Medicine. 192: 953-64. PMID 11015437 DOI: 10.1084/Jem.192.7.953 |
0.689 |
|
| 2000 |
Belvedere O, Feruglio C, Malangone W, Bonora ML, Minisini AM, Spizzo R, Donini A, Sala P, De Anna D, Hilbert DM, Degrassi A. Increased blood volume and CD34(+)CD38(-) progenitor cell recovery using a novel umbilical cord blood collection system. Stem Cells (Dayton, Ohio). 18: 245-51. PMID 10924090 DOI: 10.1634/Stemcells.18-4-245 |
0.317 |
|
| 1999 |
Gronowski AM, Hilbert DM, Sheehan KC, Garotta G, Schreiber RD. Baculovirus stimulates antiviral effects in mammalian cells. Journal of Virology. 73: 9944-51. PMID 10559307 DOI: 10.1128/Jvi.73.12.9944-9951.1999 |
0.372 |
|
| 1999 |
Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, ... ... Hilbert DM, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science (New York, N.Y.). 285: 260-3. PMID 10398604 DOI: 10.1126/Science.285.5425.260 |
0.658 |
|
| 1998 |
Hilbert DM, Theisen PW, Rudikoff EK, Bauer SR. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice. Oncogene. 17: 2125-35. PMID 9798684 DOI: 10.1038/Sj.Onc.1202134 |
0.552 |
|
| 1996 |
Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology. 140: 173-9. PMID 8806883 DOI: 10.1006/Taap.1996.0210 |
0.338 |
|
| 1996 |
Hilbert DM, Migone TS, Kopf M, Leonard WJ, Rudikoff S. Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity. 5: 81-9. PMID 8758897 DOI: 10.1016/S1074-7613(00)80312-X |
0.408 |
|
| 1996 |
Lisignoli G, Monaco MC, Facchini A, Toneguzzi S, Cattini L, Hilbert DM, Lavaroni S, Belvedere O, Degrassi A. In vitro cultured stromal cells from human tonsils display a distinct phenotype and induce B cell adhesion and proliferation. European Journal of Immunology. 26: 17-27. PMID 8566062 DOI: 10.1002/Eji.1830260104 |
0.452 |
|
| 1995 |
Hilbert DM, Shen MY, Rapp UR, Rudikoff S. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proceedings of the National Academy of Sciences of the United States of America. 92: 649-53. PMID 7846031 DOI: 10.1073/Pnas.92.3.649 |
0.595 |
|
| 1995 |
Hilbert DM, Kopf M, Mock BA, Köhler G, Rudikoff S. Interleukin 6 is essential for in vivo development of B lineage neoplasms. The Journal of Experimental Medicine. 182: 243-8. PMID 7790819 DOI: 10.1084/Jem.182.1.243 |
0.388 |
|
| 1995 |
Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (New York, N.Y.). 268: 722-6. PMID 7732381 DOI: 10.1126/Science.7732381 |
0.313 |
|
| 1994 |
Hilbert DM, Anderson AO, Holmes KL, Rudikoff S. Long-term lymphoid reconstitution of SCID mice suggests self-renewing B and T cell populations in peripheral and mucosal tissues. Transplantation. 58: 466-75. PMID 8073516 DOI: 10.1097/00007890-199408270-00013 |
0.494 |
|
| 1994 |
Nazarov V, Hilbert D, Wolff L. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Virology. 205: 479-85. PMID 7975249 DOI: 10.1006/Viro.1994.1668 |
0.321 |
|
| 1993 |
Degrassi A, Hilbert DM, Rudikoff S, Anderson AO, Potter M, Coon HG. In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proceedings of the National Academy of Sciences of the United States of America. 90: 2060-4. PMID 8446628 DOI: 10.1073/Pnas.90.5.2060 |
0.552 |
|
| 1993 |
Hilbert DM, Holmes KL, Anderson AO, Rudikoff S. Long-term thymic reconstitution by peripheral CD4 and CD8 single-positive lymphocytes. European Journal of Immunology. 23: 2412-8. PMID 8405041 DOI: 10.1002/Eji.1830231006 |
0.372 |
|
| 1990 |
Degrassi A, Hilbert DM, Anderson AO, Potter M, Coon HG. In vitro culture of a primary plasmacytoma that has retained its dependence on pristane conditioned microenvironment for growth. Current Topics in Microbiology and Immunology. 166: 71-4. PMID 2073818 DOI: 10.1007/978-3-642-75889-8_10 |
0.41 |
|
| 1986 |
Hilbert DM, Cancro MP. A comparative analysis of the anti-phosphorylcholine response of CLA and BALB/c mice. Current Topics in Microbiology and Immunology. 127: 206-17. PMID 3089697 DOI: 10.1007/978-3-642-71304-0_24 |
0.459 |
|
| 1983 |
Cancro MP, Thompson MA, Hilbert DM. Developmental aspects of B-cell repertoire phenotype. Survey of Immunologic Research. 2: 62-77. PMID 6359323 DOI: 10.1007/BF02918397 |
0.806 |
|
| Show low-probability matches. |